On November 28th, the Taiwan Stock Exchange approved the IPO of Qing Song Health (6931), marking a historic milestone for the nation’s long-term care industry. Founded in 1996, Qing Song Health has nearly 30 years of expertise, offering comprehensive care solutions ranging from in-home services to community and residential care.
 
As aging populations become a global phenomenon—not just confined to high-income countries like Japan—major pharmaceutical companies and healthcare providers worldwide are venturing into long-term care. This shift not only reflects the growing demand for elder care but also serves as a strategic transformation for these enterprises.
 
From developing innovative therapies to integrating care services with advanced technology, the healthcare sector is reshaping its approach to elder care. But how exactly are industry giants contributing to this evolving landscape, and what milestones have they achieved so far?
 
Follow #Globalbio for an in-depth look at long-term care innovation and the role of biotech in aging populations.
#AgingPopulation #LongTermCare #ElderCareInnovation #HealthcareLeadership